Vilin Bio Med (NSE:VILINBIO) Total Operating Expense: ₹12.9 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VILINBIO Vilin Bio Med Ltd NSE:VILINBIO
69 GF Score
Price ₹44.70
GF Value ₹75.10
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vilin Bio Med Total Operating Expense?

Vilin Bio Med NSE:VILINBIO +4.93% 69 Total Operating Expense is ₹12.9 Mil as of Mar. 2026. GuruFocus rates NSE:VILINBIO with a GF Score™ of 69/100 and a GF Value™ of ₹75.10 (Possible Value Trap). The stock has 4 warning signs investors should review.

Vilin Bio Med's Total Operating Expense for the six months ended in Mar. 2026 was ₹12.9 Mil. Vilin Bio Med's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹12.9 Mil.

Vilin Bio Med Total Operating Expense Related Terms

Vilin Bio Med Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Vilin Bio Med's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vilin Bio Med Total Operating Expense Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial 15.82 26.28 13.76 6.55 17.27

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.03 -1.27 3.68 2.87 12.92
NSE:VILINBIO
69GF Score
Vilin Bio Med Ltd NSE:VILINBIO
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vilin Bio Med Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹12.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹12.9 Mil mean?
Vilin Bio Med (NSE:VILINBIO) has a Total Operating Expense of ₹12.9 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vilin Bio Med and its competitors.
Is Vilin Bio Med's Total Operating Expense too high?
Vilin Bio Med's current Total Operating Expense is ₹12.9 Mil. Overall, Vilin Bio Med has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vilin Bio Med's Total Operating Expense compare to ZTS?
Vilin Bio Med's Total Operating Expense of ₹12.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vilin Bio Med and its competitors. Vilin Bio Med's current Total Operating Expense is ₹12.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vilin Bio Med stock overvalued right now?
Based on GuruFocus' analysis, Vilin Bio Med (NSE:VILINBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹75.10, compared to a current price of ₹44.70 — trading 40.5% below its estimated fair value. The current Total Operating Expense is ₹12.9 Mil. Vilin Bio Med's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Vilin Bio Med (NSE:VILINBIO), the current Total Operating Expense is ₹12.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vilin Bio Med (NSE:VILINBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Vilin Bio Med stock appears to be undervalued. The current stock price of ₹44.70 is trading 40.5% below its estimated GF Value™ of ₹75.10. GuruFocus considers Vilin Bio Med to be Possible Value Trap.

Key valuation signals for NSE:VILINBIO:

  • Total Operating Expense: ₹12.9 Mil
  • GF Value™: ₹75.10 vs. price of ₹44.70 (40.5% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the NSE:VILINBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vilin Bio Med Business Description

Address Road No. 2, Banjara Hills, H. No. 8-2-269/S/43, Plot No. 43, Sagar Co-operative Housing Society, Khairatabad, Hyderabad, TG, IND, 500034
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules and Nutritional Food supplements.
69GF Score

Get the complete analysis for NSE:VILINBIO

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹44.70
Price
₹75.10
GF Value